definiens: shall mean, with respect to a Committed LeadTarget and/or its corresponding Licensed Products, any and all Patents tha t are Controlled byGSK and/or its Affiliates during the Term, that arose from the development, manufactureand / or commercialization of such Committed Lead Target and/or Licens ed Products, asapplicable, by or on behalf of [COMPANY], but excluding [COMPANY] Background Know - How and GSKEvaluation Know - How . Notwithstanding the foregoing, when the term is applied to [COMPANY] ’s license grant to FivePr ime under Section 10.5.1(d)with respect to any Terminated Product, [COMPANY] Licensed Product Patents shall include any andall Patents that are Controlled by [COMPANY] and/or its Affiliates a s of the date such TerminatedProduct becomes a * * * INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WASREQUESTED . ALL SUCH OMITTED MATERIAL WAS FILED SEPAR ATELY WITH THE SECURITIES ANDEXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATE D UNDER THE SECURITIES ACT OF 1933,AS AMENDED